Tissue and blood sample collection and pathology services for lymphoma and CLL patients

Core D: Biospecimen and Pathology Core

['FUNDING_OTHER'] · BAYLOR COLLEGE OF MEDICINE · NIH-11178380

Collecting tissue and blood samples and providing pathology testing to help researchers studying lymphoma and chronic lymphocytic leukemia.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorBAYLOR COLLEGE OF MEDICINE (nih funded)
Locations1 site (HOUSTON, UNITED STATES)
Trial IDNIH-11178380 on ClinicalTrials.gov

What this research studies

This program collects and banks tumor tissue, blood, and related samples from people with lymphoma and CLL at Baylor, Houston Methodist, and affiliated hospitals in the Texas Medical Center. Expert pathologists and technologists prepare samples, run special stains, perform flow cytometry, laser capture microdissection, create tissue microarrays, and detect minimal residual disease or viral RNAs so samples are ready for research. Stored samples are shared with the SPORE research projects and approved external investigators to speed discoveries and new tests. If you are treated at a participating hospital you may be asked to allow leftover biopsy or blood to be banked for future research that could help others with your condition.

Who could benefit from this research

Good fit: People with lymphoma or chronic lymphocytic leukemia treated at the participating hospitals who can provide biopsy tissue or blood samples are the ideal candidates for contribution.

Not a fit: People without lymphoma or CLL, or those treated outside the participating hospitals or unable to provide samples, are unlikely to be eligible or to receive direct benefits from this core.

Why it matters

Potential benefit: If successful, this core can speed development of better diagnostics and treatments for lymphoma and CLL by giving researchers access to high-quality patient samples.

How similar studies have performed: Biospecimen and pathology cores are standard at major cancer centers and have previously enabled many successful discoveries and clinical advances in blood cancers.

Where this research is happening

HOUSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.